1. Home
  2. BAND vs HELP Comparison

BAND vs HELP Comparison

Compare BAND & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$15.58

Market Cap

395.6M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$8.10

Market Cap

366.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAND
HELP
Founded
2000
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.6M
366.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BAND
HELP
Price
$15.58
$8.10
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$20.40
$95.00
AVG Volume (30 Days)
428.8K
579.8K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$204,113,000.00
N/A
Revenue This Year
$17.15
N/A
Revenue Next Year
$7.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.26
N/A
52 Week Low
$11.33
$5.76
52 Week High
$18.63
$8.23

Technical Indicators

Market Signals
Indicator
BAND
HELP
Relative Strength Index (RSI) 64.67 64.44
Support Level $15.02 $7.33
Resistance Level $16.64 $8.23
Average True Range (ATR) 0.96 0.61
MACD 0.25 0.17
Stochastic Oscillator 76.59 98.06

Price Performance

Historical Comparison
BAND
HELP

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: